Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001062822-11-000021
Filing Date
2011-03-16
Accepted
2011-03-16 08:17:35
Documents
8
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K form10k12312010.htm 10-K 1784309
2 CONSULTING AGREEMENT exh106philbrownconsultinga.htm EX-10.6 38269
3 SUBSIDIARIES exh211subsidiaries.htm EX-21.1 7417
4 ERNST & YOUNG LLP CONSENT exh231ernstyoungconsent.htm EX-23.1 5539
5 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER exh311certificationofprinc.htm EX-31.1 16104
6 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER exh312certificationofprinc.htm EX-31.2 16209
7 CERTIFICATION OF PRINCIPAL EXECUTIVE AND PRINCIPAL FINANCIAL OFFICERS exh321certifications20101231.htm EX-32.1 10746
8 finalperformancegraph2.jpg GRAPHIC 87239
  Complete submission text file 0001062822-11-000021.txt   2000042
Mailing Address 8800 TECHNOLOGY FOREST PLACE THE WOODLANDS TX 77381
Business Address 8800 TECHNOLOGY FOREST PLACE THE WOODLANDS TX 77381 2818633000
LEXICON PHARMACEUTICALS, INC./DE (Filer) CIK: 0001062822 (see all company filings)

EIN.: 760474169 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30111 | Film No.: 11690367
SIC: 2834 Pharmaceutical Preparations